Cart
sales@molnova.com
Balamapimod
CAS No. 863029-99-6
Balamapimod( MKI-833 | MKI833 )
Catalog No. M16245 CAS No. 863029-99-6
Balamapimod (MKI-833) is an orally active, reversible Ras/Raf/MEK inhibitor developed for antineoplastic potential.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 873 | Get Quote |
|
| 50MG | 1782 | Get Quote |
|
| 100MG | 2250 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBalamapimod
-
NoteResearch use only, not for human use.
-
Brief DescriptionBalamapimod (MKI-833) is an orally active, reversible Ras/Raf/MEK inhibitor developed for antineoplastic potential.
-
DescriptionBalamapimod (MKI-833) is an orally active, reversible Ras/Raf/MEK inhibitor developed for antineoplastic potential.
-
In Vitro——
-
In Vivo——
-
SynonymsMKI-833 | MKI833
-
PathwayMAPK/ERK Signaling
-
TargetRaf
-
RecptorRaf
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number863029-99-6
-
Formula Weight574.144
-
Molecular FormulaC30H32ClN7OS
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN#CC1=C(NC2=CC=C(SC3=NC=CN3C)C(Cl)=C2)C4=CC(OC)=C(N5CCC(N6CCCC6)CC5)C=C4N=C1
-
Chemical Name4-[[3-Chloro-4-[(1-methyl-1H-imidazol-2-yl)thio]phenyl]amino]-6-methoxy-7-[4-(1-pyrrolidinyl)-1-piperidinyl]-3-quinolinecarbonitrile
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Sorafenib
A potent, orally available Raf inhibitor with IC50 of 6, 22, and 38 nM for Raf-1, wt Braf, and BRaf V599E, respectively.
-
SB-590885
A potent and selective B-Raf inhibitor with Kd of 0.3 nM.
-
AZ304
AZ304 is a novel potent, dual BRAF inhibitor targeting the kinase domains of wild type BRAF, V600E mutant BRAF and wild type CRAF with IC50 of 79 nM, 38 nM and 68 nM, respectively.
